HEATHER SELF: Open Payments
NPI 1336611714 · MACON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,285 in 57 payments from 17 companies in 2025. Trend: 2023 $2,092 · 2024 $2,528 · 2025 $1,285
Food & beverage: $1,271Education: $14
| Company | Payments | Amount |
|---|---|---|
| AKEBIA THERAPEUTICS INC | 6 | $236 |
| Otsuka America Pharmaceutical, Inc. | 8 | $221 |
| Amgen Inc. | 8 | $167 |
| Novartis Pharmaceuticals Corporation | 6 | $137 |
| Ardelyx, Inc. | 6 | $109 |
| Aurinia Pharma U.S., Inc. | 3 | $70 |
| Travere Therapeutics, Inc. | 6 | $67 |
| Vifor Pharma, Inc. | 2 | $50 |
| Novo Nordisk Inc | 2 | $40 |
| Calliditas Therapeutics US Inc. | 2 | $40 |
Products named: Vafseo, JYNARQUE, KRYSTEXXA, Fabhalta, IBSRELA, LUPKYNIS, Veltassa, Ozempic.
Industry payments across GA — which companies pay providers there.
